- Medical School - Soochow Medical College (1985-1990)
- Other Post Graduate Training - Soochow Medical College- Master degree of Biochemistry (1990-1993)
- Fellowship - University of Texas Medical Branch (2001-2002), Hyperbaric Medicine
- Fellowship - University of Texas Medical Branch (2005-2007), Medical Oncology
- Residency - University of Texas Medical Branch (2002-2005), Internal Medicine
Jue Wang, M.D.
- Internal Medicine - Hematology/Oncology
- Genitourinary Cancer
- Bladder Cancer
Dr. Wang earned his medical degree at Suzhou Medical College in China. He received advanced cancer research training at the Institute of Cancer Research and Royal Marsden Hospital in England, as well as at the Sealy Center for Molecular Hematology and Oncology at the University of Texas Medical Branch at Galveston (UTMB). Also at UTMB, he completed his residency in internal medicine and separate fellowships in hyperbaric medicine and medical oncology.
Certified in internal medicine and medical oncology by the American Board of Internal Medicine, he joined UT Southwestern in 2023. He previously served as Professor of Medicine and Interdisciplinary Oncology at the University of Arizona and Professor of Medicine at Creighton University. His clinical expertise includes treating patients with bladder, kidney, prostate, penile, and testicular cancer.
Dr. Wang’s research focuses on understanding the molecular mechanisms that underlie advanced genitourinary cancer and developing new strategies that improve the efficacy of cancer treatments and prevent or reduce treatment-related toxicity. He also conducts studies on the processes and patterns of decision making in cancer doctors and cancer patients, with the goal of optimizing patient-centered care.
His investigations have resulted in 120 publications in peer-reviewed journals and contributions to several medical textbooks related to the field of cancer medicine and infection. Dr. Wang is also a co-inventor of Genomic Patient Intelligence (GPI), an electronic health record-based solution that allows clinicians to collect, store, and integrate genomics information to enhance precision medicine decision making and delivery of personalized cancer therapies for cancer patients.
He is a Fellow of the American College of Physicians and an active member of several other professional organizations, including the American Society of Clinical Oncology and the American College of Physicians.
He is the Editor-in-Chief of Journal of Tumor Research, Annals of Men’s Health and Wellness, and Journal of Molecular Cancer, as well as the Prostate Cancer Section Editor for Advances in Oncology.
Dr. Wang has received numerous awards for exceptional patient care and for his achievements in teaching and research. In 2020 he received the Faculty Service Award from the University of Arizona College of Medicine; in 2022 he received the Silver Certification of Excellence from the National Cancer Institute and the Certificate of Excellence in Clinical Research from the SWOG Cancer Research Network.
A passionate patient advocate, Dr. Wang is a frequent speaker at community events geared toward educating cancer patients about navigating the complex health care environment and optimizing their cancer journey.
Viewing medicine as a personal calling, Dr. Wang is committed to delivering compassionate, high-quality care to patients and families. He aims to maximize the benefits of cancer treatments and minimize their negative impact on patients’ quality of life.
Outside of work, he enjoys spending time with his family, cooking, reading, and learning to play the piano.
- Alliance for Clinical Trials in Oncology
- American College of Physicians
- American Society of Clinical Oncology
- CORA–CIRI Oncology Alliance
- International Society of Geriatric Oncology
- Hoosier Cancer Research Network Clinical Trial Working Groups
- Society for Basic Urologic Research
- Southwest Oncology Group (SWOG)
- America’s Top Doctor (Medical Oncology) 2013-2023, Castle Connolly Medical, Ltd.
- Patient-Nominated Outstanding Patient Care Certificate of Appreciation, National Doctor’s Day 2017-2022, St. Joseph’s Foundation
- Certificate of Excellence in Clinical Research 2022, SWOG Cancer Research Network
- Silver Certification of Excellence for Exceptional Achievement in Patient Enrollments 2022, National Cancer Institute Treatment and Cancer Control, Prevention, and Screening Trials
- Top Arizona Hematologist-Oncologist 2022, Waiting Room Magazine
- Top Doctor of Arizona 2022, Modern Luxury Magazine
- Top Doctors in Scottsdale 2022, Modern Luxury Magazine
- Faculty Service Award 2020, University of Arizona College of Medicine
- Educational Award 2007-2008, International Society of Gastrointestinal Oncology
Molecular Genetics of Nervous System Hereditary Diseases in Neurochemistry and Molecular Biology
Wang J, Wang Y (1997), Beijing, China , People’s Medical Publishing House
Gene Cloning and Expression in Central Nervous System in Neurochemistry and Molecular Biology
Wang J, Wang Y (1997), Beijing, China , People’s Medical Publishing House
Gene Therapy in Musculoskeletal Repair: State-of-Art in Musculoskeletal Infections
Wang J, Calhoun JH, Mader JT (2002), New York, NY , Marcel Dekker
Musculoskeletal Infection in Systemically and Locally Immunocompromised Hosts in Musculoskeletal Infections
Wang J, Calhoun JH, Mader JT (2002), New York, NY , Marcel Dekker
The Roles and Effectiveness of Adjunctive Therapy in the Management of Musculoskeletal Infections in Musculoskeletal Infections
Wang J, Calhoun JH, Mader JT (2002), New York, NY, Marcel Dekker, Inc.
Osteomyelitis in Expert Guide to Infectious Diseases
Mader JT, Wang J, Shirtiff, ME, Calhoun JH (2002), Philadelphia, PA , American College of Physicians, Am Soc Int Med
Antibiotic Therapy for Musculoskeletal Infections in Instructional Course Lectures, American Academy of Orthopedic Surgeons
Mader JT, Wang J, Calhoun JH (2002), Rosemont, IL
Infections Associated with Hyperbaric Oxygen Therapy and Hyperbaric Chambers and Research in Altitude Chambers in Hospital Epidemiology and Infection Control (3e.)
Mader JT, Wang J (2004), Philadelphia, PA, Lippincott Williams & Wilkins
Primary Sarcomas and Other Sarcomatoid Tumors of the Bladder in Rare Genitourinary Tumors
Wang J; Malla M; Wang JF (2016), Switzerland , Springer International Publishing
The Emerging Role of PARP Inhibitors in the Treatment of Prostate Cancer in Prostate Cancer – Leading-Edge Diagnostic Procedures and Treatments
Wang J, Freeman B, Mathew P (2016), InTech
Long-Term Outcomes of Radical Prostatectomy for Clinically Localized Prostate Adenocarcinoma in Recent Advances in Prostate Cancer
Bhatt V, Post CM, Dahal S, Loberiza FR and Wang J (2017), Berlin, Germany, Avid Science Borsigstr
Comparative Survival of Patients with Sarcoma and Sarcomatoid Carcinoma, and High Grade Urothelial Carcinoma of the Urinary Bladder in Recent Advances in Bladder Cancer
Wang J (2017), Berlin, Germany, Avid Science Borsigstr
Clinical Features, Treatment and Survival Outcome of Testicular Germ Cell Tumors in Men with Down's Syndrome in Top 25 Contributions on Cancer Research
Weatherford E, Wang J, Berlin, Germany, Avid Science Borsigstr
Disseminated intravascular coagulation secondary to advanced prostate cancer: Clinical characteristics, management, and prognosis in Top 25 Contributions on Cancer Research
Benny Ni, Wang J, Berlin, Germany, Avid Science Borsigstr
ellular Prostatic Acid Phosphatase (cPAcP) serves as a Useful Biomarker of Histone Deacetylase (HDAC) Inhibitors in Prostate Cancer Cell Growth Suppression in Top 10 Contributions on Cell Biology
Chou YW, Miller D, Lin FF, Lin FC, Wang J, Huang CC and Lin MF, Berlin, Germany, Avid Science Borsigstr
Older age and liver metastases predict poor prognosis of Tumor Lysis Syndrome in Solid Tumor in Top 25 Contributions on Cancer Research
Wang JF, Harmon J, Allen S, Cassaday J, Ruvinov K, Stoyanova D, Tadipatri R, Wang J, Berlin, Germany, Avid Science Borsigstr
Comprehensive genomic sequencing of prostatic sarcomatoid carcinoma tumors identifies differences in genomic alterations in comparison to prostatic adenocarcinoma tumors in Top 25 Contributions on Cancer Research
Marsh S, Millis S, Ross JS, Stephens PJ, Miller V, Ali S, Wang J, Berlin, Germany, Avid Science Borsigstr
Comprehensive Genomic Characterization of Small Cell Bladder Cancers Reveals Novel Therapeutic Targets in Top 10 Commentaries in Bladder Cancer
Zeng J, Wang J, Avid Science
- Molecular Genetics of Nervous System Hereditary Diseases in Neurochemistry and Molecular Biology
Treatment-Refractory, Castration-Resistant Prostate Cancer With Liver Metastasis: A Promising Modality of Therapy.
Findakly D, Duong T, Shimon T, Wang J, Cureus 2022 Jul 14 7 e26881
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.
Patel SP, Mayerson E, Chae YK, Strosberg J, Wang J, Konda B, Hayward J, McLeod CM, Chen HX, Sharon E, Othus M, Ryan CW, Plets M, Blanke CD, Kurzrock R, Cancer 2021 Sep 127 17 3194-3201
Association of Tumor Lysis Syndrome and Metastatic Melanoma.
Kelkar N, Wang J, Cureus 2021 Sep 13 9 e18108
Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
Santha S, Ling X, Aljahdali IAM, Rasam SS, Wang X, Liao J, Wang J, Fountzilas C, Li Q, Qu J, Li F, Cancers 2020 Nov 12 11
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study.
Grivas P, Lalani AA, Pond GR, Nagy RJ, Faltas B, Agarwal N, Gupta SV, Drakaki A, Vaishampayan UN, Wang J, Barata PC, Gopalakrishnan D, Naik G, McGregor BA, Kiedrowski LA, Lanman RB, Sonpavde GP, European urology oncology 2020 Oct 3 5 695-699
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer.
Galsky MD, Mortazavi A, Milowsky MI, George S, Gupta S, Fleming MT, Dang LH, Geynisman DM, Walling R, Alter RS, Kassar M, Wang J, Gupta S, Davis N, Picus J, Philips G, Quinn DI, Haines GK, Hahn NM, Zhao Q, Yu M, Pal SK, Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Jun 38 16 1797-1806
Tumor Lysis Syndrome in Solid Tumors: A Comprehensive Literature Review, New Insights, and Novel Strategies to Improve Outcomes.
Findakly D, Luther RD, Wang J, Cureus 2020 May 12 5 e8355
Misdiagnosis of Small Cell Prostate Cancer: Lessons Learned.
Findakly D, Wang J, Cureus 2020 May 12 5 e8356
A Retrospective Review of Tumor Lysis Syndrome Associated With Colorectal Cancer.
Ansari Z, Findakly D, Wang J, Cureus 2020 May 12 5 e8257
Molecular Profiling of Benign Metastasizing Leiomyoma of the Uterus Revealing Unique Novel Therapeutic Targets.
Findakly D, Wang J, Cureus 2020 Apr 12 4 e7701
Intricate Interplay of Entwined Metabolic and Inflammatory Life-threatening Processes in Tumor Lysis Syndrome Complicating Prostate Cancer: A Systematic Review with a Single Institution Experience.
Findakly D, Wang J, Cureus 2020 Mar 12 3 e7395
Tumor Lysis Syndrome Associated with Breast Cancer, A Previously Unrecognized Oncologic Emergency
Bell B, Maas D, Habib N, Wang J. Emergency Medicine and Critical Care 2020 1 4 1-5
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
Sonpavde G, Agarwal N, Pond GR, Nagy RJ, Nussenzveig RH, Hahn AW, Sartor O, Gourdin TS, Nandagopal L, Ledet EM, Naik G, Armstrong AJ, Wang J, Bilen MA, Gupta S, Grivas P, Pal SK, Lanman RB, Talasaz A, Lilly MB, Cancer 2019 May 125 9 1459-1469
Tumor Lysis Syndrome Associated with Urothelial Cancer: A Case Series
Hernandez R, Cassaday J, Wang JF, Tang T, Wang J. Archives of Clinical Case Studies 2019 3 1
Clinical Features, Treatment, and Outcome of Tumor Lysis Syndrome in Germ Cell Tumors
Leung B, Wang JF, Cassaday J, Wang J. Journal of Urology & Nephrology Studies 2019 4 1
Tumor lysis syndrome associated with renal cell carcinoma
Wang JF, Mass D, Luther R, Wang J International Medicine 2019 Int Med 2019; 1(2): 97-100 Int Med 2019; 1(2): 97-100 97-100
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA.
Agarwal N, Pal SK, Hahn AW, Nussenzveig RH, Pond GR, Gupta SV, Wang J, Bilen MA, Naik G, Ghatalia P, Hoimes CJ, Gopalakrishnan D, Barata PC, Drakaki A, Faltas BM, Kiedrowski LA, Lanman RB, Nagy RJ, Vogelzang NJ, Boucher KM, Vaishampayan UN, Sonpavde G, Grivas P, Cancer 2018 May 124 10 2115-2124
Spontaneous Tumor Lysis Syndrome in a Giant Neglected Breast Cancer
Cordrey EO, Dienhart JA, Wang J. 2018 2 2 38-41
Durable complete response to sequential administration of mitoxantrone followed by anti‐programmed cell death protein 1 antibody in a patient with JAK1 mutated refractory prostate cancer.
Tadipatri R, Wang J. 2018 1 2 1012-16
Testicular Germ Cell Tumors in Men with Downs Syndrome: Delayed Diagnosis, Comorbidities May Contribute to the Suboptimal Outcome
Weatherford E, Wang J. Ann Mens Health Wellness 2018 1 2 1010-14
Clinical Features, Prognosis, and Outcome of Patients with Pure Squamous Cell Carcinoma of the Prostate
Brunnhoelzl D, Wang J. 2018 1 2
Tumor lysis syndrome associated with CTLA4 and PD1 blocking immunotherapy in solid tumor
Cordrey E, Wang J Japanese Journal of Cancer and Oncology Research 2018 1 1 1005.-7
Complete pathological remission after treatment with olaparib in a patient with TMPRSS2-ERG, PTEN-deficient sarcomatoid prostate cancer
Wang J. J Mol Cancer 2018 2018; 2 (1): 15-19. J Mol Cancer 2018; 2 (1): 15-19. J Mol Cancer 15-19
Sarcomatoid Carcinoma of the Prostate
Ross M, Roy SB, Brunnhoelzl D, Raj J, Wang J. Ann Mens Health Wellness 2018, 2(1): 1008. 2018 Ann Mens Health Wellness 2018, 2(1): 1008. Ann Mens Health Wellness 2018, 2(1): 1008. 1008-10
Molecular evidence of Warburg-like metabolic reprogramming in metastatic prostate cancer
Pecci C, Wang J. Annals of Mens Health and Wellness 2018 2018, 2(1): 1011. 2018, 2(1): 1011. 1-4
Tumor Lysis Syndrome Associated with Prostate Cancer: An Under-recognized Oncologic Emergency
Wang J. 2018 1 1 1-3
Next-Generation Sequencing of Locally Advanced Squamous Cell Penile Carcinoma Reveals Novel Druggable Targets
Cheney S, Brunnhoelzl D, Nallagangula A, Bhavsar S, Trepeta R, Wang J 2017 BJBMR 1(1) 289-299 BJBMR 1(1) 289-299 BJBMR 1(1) 289-299
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.
Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM, Oncotarget 2015 Dec 6 41 43594-604
The Natural History, Treatment Pattern, and Outcomes of Patients With Micropapillary Bladder Carcinoma.
Wang J, Wang FW, American journal of clinical oncology 2015 Oct 38 5 472-8
Lenalidomide and cyclophosphamide immunoregulation in patients with metastatic, castration-resistant prostate cancer.
Wang J, McGuire TR, Britton HC, Schwarz JK, Loberiza FR, Meza JL, Talmadge JE, Clinical & experimental metastasis 2015 Feb 32 2 111-24
Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.
Chou YW, Lin FF, Muniyan S, Lin FC, Chen CS, Wang J, Huang CC, Lin MF, Cell & bioscience 2015 5 38
Safety and efficacy of preoperative sorafenib therapy in facilitating cytoreductive surgery in renal cell carcinoma.
Bhatt VR, Ganti AK, Schwarz JK, Wang J, Future oncology (London, England) 2014 Apr 10 5 703-6
Kidney cancer, version 2.2014.
Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Sircar K, Somer B, Wang J, Wilder RB, Dwyer MA, Kumar R, Journal of the National Comprehensive Cancer Network : JNCCN 2014 Feb 12 2 175-82
Risk factors, therapy and survival outcomes of small cell and large cell neuroendocrine carcinoma of urinary bladder.
Bhatt VR, Loberiza FR, Tandra P, Krishnamurthy J, Shrestha R, Wang J, Rare tumors 2014 Jan 6 1 5043
Impact of age on clinical presentation, treatment, and cancer-specific survival of patients with small-cell carcinoma of the prostate.
Wang J, Wang FW, Clinical interventions in aging 2013 8 871-7
Calcaneal acrometastasis from urothelial carcinoma of the ureter: a case report and literature review.
Ryder JH, McGarry SV, Wang J, Clinical interventions in aging 2013 8 395-9
The impact of signet-ring cell carcinoma histology on bladder cancer outcome.
Wang J, Wang FW, Kessinger A, World journal of urology 2012 Dec 30 6 777-83
Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium.
Beer TM, Smith DC, Hussain A, Alonso M, Wang J, Giurescu M, Roth K, Wang Y, British journal of cancer 2012 Aug 107 5 808-13
Metastases from nested variant urothelial carcinoma of the urinary bladder in pancreatic allograft mimicking graft rejection.
Wang J, Talmon G, Kazmi SA, Siref LE, Morris MC, Journal of clinical medicine research 2012 Apr 4 2 145-8
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB, Journal of the National Comprehensive Cancer Network : JNCCN 2012 Apr 10 4 502-35
Targeting Tumor-Related Immunosuppression using Metronomic Cyclophosphamide in Combination with Lenalidomide -New Mechanisms for Old Drugs
Wang J, Talmadge JE. Chemotherapy 2012 3 1 110-3
Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis.
Wang J, Talmon G, Hankins JH, Enke C, Case reports in oncology 2012 Jan 5 1 9-16
Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.
Chou YW, Chaturvedi NK, Ouyang S, Lin FF, Kaushik D, Wang J, Kim I, Lin MF, Cancer letters 2011 Dec 311 2 177-86
Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell carcinoma.
Wang J, Talmon GA, Feloney M, Morris MC, World journal of surgical oncology 2011 Nov 9 155
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Carducci MA, Chang SS, Choueiri TK, Hancock SL, Hudes GR, Jonasch E, Josephson D, Kuzel TM, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Spiess PE, Wang J, Wilder RB, Journal of the National Comprehensive Cancer Network : JNCCN 2011 Sep 9 9 960-77
Sarcomatoid Urothelial Carcinoma: A Single Cancer Center Experience.
Wang J, Gillaspie C, Kunadharaju R, Talmon GA, Enke C, World journal of oncology 2011 Aug 2 4 175-180
The Impact of Radical Prostatectomy on the Survival of Patients with Carcinosarcoma of the Prostate
Wang J, Wang FW Journal of Cancer Therapy 2011 JCT 2011; 2:475-80 JCT 2011; 2:475-80 475-80
Teratoma with malignant transformation: a case report with pathological, cytogenetic, and immunohistochemistry analysis.
Wang J, Kazmi SA, Sarcoma 2011 2011 450743
Younger age is an independent predictor for poor survival in patients with signet ring prostate carcinoma.
Wang J, Wang FW, Hemstreet GP, Prostate cancer 2011 2011 216169
Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.
Wang J, Wang FW, Urologia internationalis 2011 86 4 453-60
The natural history and outcomes of the patients with carcinosarcoma involving kidney and renal pelvis.
Wang J, Wang FW, Kessinger A, Advances in urology 2011 2011 693964
Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate.
Wang J, Wang FW, Lagrange CA, Hemstreet GP, Rare tumors 2010 Sep 2 3 e47
Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases.
Wang J, Wang FW, Lagrange CA, Hemstreet Iii GP, Kessinger A, Sarcoma 2010 2010
Outcome of combined hepatocellular and cholangiocarcinoma of the liver.
Wang J, Wang F, Kessinger A, Journal of oncology 2010 2010
Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma.
Wang J, Wang FW, International journal of surgical oncology 2010 2010 381795
NCCN clinical practice guidelines in oncology: testicular cancer.
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J, Wang J, Journal of the National Comprehensive Cancer Network : JNCCN 2009 Jun 7 6 672-93
NCCN clinical practice guidelines in oncology: kidney cancer.
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J, Wang J, Journal of the National Comprehensive Cancer Network : JNCCN 2009 Jun 7 6 618-30
Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer.
Wang J, Kuo YF, Freeman J, Markowitz AB, Goodwin JS, Cancer 2008 Jan 112 2 382-90
Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancer.
Wang J, Kuo YF, Freeman J, Goodwin JS, Medical oncology (Northwood, London, England) 2008 25 2 125-32
Hyperbaric oxygen as adjunctive therapy in Vibrio vulnificus septicemia and cellulitis.
Wang J, Corson K, Mader J, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2004 31 1 179-81
The application of bioimplants in the management of chronic osteomyelitis.
Wang J, Calhoun JH, Mader JT, Orthopedics 2002 Nov 25 11 1247-52
Mycobacterium tuberculosis and Mycobacterium fortuitum osteomyelitis of the foot and septic arthritis of the ankle in an immunocompetent patient.
Lazzarini L, Amina S, Wang J, Calhoun JH, Mader JT, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2002 Jun 21 6 468-70
The role and effectiveness of adjunctive hyperbaric oxygen therapy in the management of musculoskeletal disorders.
Wang J, Li F, Calhoun JH, Mader JT, Journal of postgraduate medicine 2002 48 3 226-31
Diver with acute abdominal pain, right leg paresthesias and weakness: a case report.
Wang J, Corson K, Minky K, Mader J, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2002 29 4 242-6
Systemic Apophysomyces elegans after trauma: case report and literature review.
Wang J, Harvey CM, Calhoun JH, Yin LY, Mader JT, Surgical infections 2002 3 3 283-9
Antibiotic therapy for musculoskeletal infections.
Mader JT, Wang J, Calhoun JH, Instructional course lectures 2002 51 539-51
Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells.
Davis BR, Yannariello-Brown J, Prokopishyn NL, Luo Z, Smith MR, Wang J, Carsrud ND, Brown DB, Blood 2000 Jan 95 2 437-44
ICAAR, a novel member of a new family of transmembrane, tyrosine phosphatase-like proteins.
Smith PD, Barker KT, Wang J, Lu YJ, Shipley J, Crompton MR, Biochemical and biophysical research communications 1996 Dec 229 2 402-11
- Treatment-Refractory, Castration-Resistant Prostate Cancer With Liver Metastasis: A Promising Modality of Therapy.
- Clinical and translation research of genitourinary malignancies
- Defining and characterizing clinical presentation and underlying mechanisms of cancer treatment-related toxicities, with the goal of developing early intervention and novel strategies to prevent or reduce morbidity and mortality of cancer or cancer treatment
- Genitourinary Cancer
- Bladder Cancer
- Kidney Cancer
- Prostate Cancer
- Testicular Cancer
- Penile Cancer